|
|
2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
CERTs Publications 2002
- Allen LaPointe NM, Kramer JM, DeLong E, Ostbye T, Hammill BG, Muhlbaier
LH, McCants CB, Chen A, Califf RM. Patient-reported
frequency of taking aspirin in a population with coronary artery disease.
Am J Cardiol 2002;89:1042-1046.
- Allen LaPointe NM, Kramer JM, Weinfurt K, Califf RM. Practitioner
acceptance of the dofetilide risk-management program. Pharmacotherapy
2002;22:1041-1046.
- Andrade SE, Gurwitz JH, Chan KA, Donahue JH, Beck A, Boles M, Buist
DS, Goodman M, LaCroix AZ, Levin TR, Platt R. Validation
of diagnoses of peptic ulcers and bleeding from administrative databases.
A multi-health maintenance organization study. J Clin Epidemiol
2002;55:310-313.
- Bisson GP, Fishman NO, Patel JB, Edelstein PH, Lautenbach E. Extended-spectrum
beta-lactamase-producing Escherichia coli and Klebsiella species: risk
factors for colonization and impact of antimicrobial formulary interventions
on colonization prevalence. Infect Control Hosp Epidemiol 2002;23:254-260.
- Butler J, Arbogast PG, BeLue R, Daugherty J, Jain MK, Ray WA, Griffin.
Outpatient
adherence to beta-blocker after acute myocardial infarction. J Am
Coll Cardiol 2002;40:1589-1595.
- Califf RM, Peterson ED, Gibbons RJ, Garson A Jr, Brindis RG, Beller
GA, Smith SC Jr; American College of Cardiology; American Heart Association.
Integrating quality into the cycle of therapeutic development. J
Am Coll Cardiol 2002;40:1895-1901.
- Califf RM. The
need for a national infrastructure to improve the rational use of therapeutics.
Pharmacoepidemiol Drug Saf 2002;11:319-327.
- Califf RM, DeLong ER, Ostbye T, Muhlbaier LH, Chen A, LaPointe NA,
Hammill B, McCants CB, Kramer JM. Underuse
of aspirin in a referral population with documented coronary artery
disease. Am J Cardiol 2002;89:653-661.
- Casebeer L, Bennett N, Kristofco R, Carillo A, Centor R. Physician
Internet medical information seeking and on-line continuing education
use patterns. J Contin Educ Health Prof 2002;22:33-42.
- Casebeer L, James N. Practice
pattern variation in the prevention and treatment of osteoporosis.
Curr Opin Rheumatol 2002;14:453-457.
- Cooper WO, Griffin MR, Arbogast P, Hickson GB, Gautan S, Ray WA. Very
early exposure to erythromycin and infantile hypertrophic pyloric stenosis.
Arch Pediatr Adolesc Med 2002;156:647-650.
- Cooper WO, Ray WA, Griffin MR. Prenatal
prescription of macrolide antibiotics and infantile hypertrophic pyloric
stenosis. Obstet Gynecol 2002;100:101-106.
- Cooper WO, Staffa J, Renfrew JW, Graham D, Renfrew W, Ray WA. Oral
corticosteroid use among children in TennCare. Ambul Pediatr 2002;2:375-381.
- Donahue JG, Chan KA, Andrade SE, Beck A, Boles M, Buist DS, Carey
VJ, Chandler JM, Chase GA, Ettinger B, Fishman P, Goodman M, Guess HA,
Gurwitz JH, LaCroix AZ, Levin TR, Platt R.
Gastric and duodenal safety of daily alendronate. Arch Intern Med
2002;162:936-942.
- Flockhart DA, Usdin Yasuda S, Pezzullo JC, Knollmann BC. Teaching
rational prescribing: a new clinical pharmacology curriculum for medical
schools. Naunyn Schmiedebergs Arch Pharmacol 2002;366:33-43.
- Gross R, Bilker WB, Friedman HM, Coyne JC, Strom BL. Provider
inaccuracy in assessing adherence and outcomes with newly initiated
antiretroviral therapy. AIDS 2002;16:1835-1837.
- Hartert TV, Speroff T, Togias A, Mitchel EF Jr, Snowden MS, Dittus
RS, Griffin MR. Risk
factors for recurrent asthma hospital visits and death among a population
of indigent older adults with asthma. Ann Allergy Asthma Immunol
2002;89:467-473.
- Katchman AN, McGroary KA, Kilborn MJ, Kornick CA, Manfredi PL, Woosley
RL, Ebert SN, Influence
of opioid agonists on cardiac human ether-a-go-go related gene (K)+ currents.
J Pharmacol Exp Ther 2002;303:688-694.
- Kramer JM, Bosco LA, Califf RM. Centers
for Education and Research on Therapeutics (CERTs). Drug Information
Journal 2002;36:717-723.
- Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein
PH, Strom BL. Risk
factors for fluoroquinolone resistance in nosocomial Escherichia coli
and Klebsiella pneumoniae infections. Arch Intern Med 2002;162:2469-2477.
- Localio AR, Berlin JA, Ten Have TR. Confounding due to cluster
in multicenter studies—causes and cures. Health Services &
Outcomes Research Methodology 2002;3:195-210.
- Meredith S, Feldman P, Frey D, Giammarco L, Hall K, Arnold K, Brown
NJ, Ray WA.
Improving medication use in newly admitted home healthcare patients:
a randomized controlled trial. J Am Geriatr Soc 2002;50:1484-1491.
- Metlay JP, Singer DE. Outcomes
in lower respiratory tract infections and the impact of antimicrobial
drug resistance. Clin Microbiol Infect 2002;8:1-11.
- Metlay JP, Shea JA, Crossette LB, Asch DA. Tensions
in antibiotic prescribing: pitting social concerns against the interests
of individual patients . J Gen Intern Med 2002;17:87-94.
- Metlay JP, Shea JA, Asch DA. Antibiotic
prescribing decisions of generalists and infectious disease specialists:
thresholds for adopting new drug therapies. Med Decis Making 2002;22:498-505.
- Mikuls TR, Saag KG, Criswell LA, Merlino LA, Kaslow RA, Shelton BJ,
Cerhan JR. Mortality
risk associated with rheumatoid arthritis in a prospective cohort of
older women: results from the Iowa Women's Health Study. Ann Rheum
Dis 2002;61:994-999.
- Moellering RC Jr, Craig W, Edmond M, Farrell DJ, Ferraro MJ, Flie TM Jr,
Klein J, Lonks J, Metlay JP, Sahm D, Talbot GH; Consensus Working Group. Clinical
and public health implications of macrolide-resistant Streptococcus
pneumoniae. J Chemother 2002;14:42-56.
- Putnam KG, Buist DS, Fishman P, Andrade SE, Boles M, Chase GA, Goodman
MJ, Gurwitz JH, Platt R, Raebel MA, Arnold Chan K. Chronic
disease score as a predictor of subsequent hospitalization. Epidemiology 2002;13:340-346.
- Ray WA, Thapa PB, Gideon P.
Misclassification of current benzodiazepine exposure by use of a single
baseline measurement and its effects upon studies of injuries. Pharmacoepidemiol
Drug Saf 2002;11:663-669.
- Ray WA, Daugherty JR, Griffin MR. Lipid-lowering
agents and the risk of hip fracture in a Medicaid population. Inj
Prev 2002;8:276-279
- Ray WA, Stein CM, Daugherty JR, Hall K, Arbogast PG, Griffin MR,
COX-2
selective non-steroidal anti-inflammatory drugs and risk of serious
coronary heart disease. Lancet 2002;360:1071-1073.
- Ray WA, Stein CM, Hall K, Daugherty JR, Griffin MR. Non-steroidal
anti-inflammatory drugs and the risk of serious coronary heart disease: an observational cohort study.
Lancet 2002;359:118-123.
- Roper WL, Hodlewsky RT, Tilson H, Lohr KN, Campbell WH. The
potential impact of measuring healthcare quality on pharmaceutical-related
costs and outcomes. Disease Management & Health Outcomes 2002;10:233-239.
- Rosebraugh CJ, Honig PK, Yasuda SU, Pezzullo JC, Woosley RL. Centers
for Education and Research on Therapeutics report: survey of medication
errors education during undergraduate and graduate medical education
in the United States. Clin Pharmacol Ther 2002;71:4-10.
- Assessing
health status and quality-of-life instruments: attributes and review
criteria. Qual Life Res 2002;11:193-205.
- Shatin D, Drinkard CR. Ambulatory
use of psychotropics by employer-insured children and adolescents in
a national managed care organization. Ambul Pediatr 2002;2:111-119.
- Smalley W, Stein CM, Arbogast PG, Eisen G, Ray WA, Griffin M. Underutilization
of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs.
Arthritis Rheum 2002;46:2195-2200.
- Yasuda SU, Zannikos P, Young AE, Fried KM, Wainer IW, Woosley RL.
The
roles of CYP2D6 and stereoselectivity in the clinical pharmacokinetics
of chlorpheniramine. Br J Clin Pharmacol 2002;53:519-525.
To Top
|